Transcatheter aortic valve replacement in the management of aortic insufficiency secondary to left ventricular assist device implantation: a case report.

Journal: Journal of thoracic disease
Published Date:

Abstract

BACKGROUND: Left ventricular assist device (LVAD) is considered either a destination therapy for patients with end-stage heart failure or heart transplantation bridging. LVAD implantation often causes aortic insufficiency (AI), which requires aortic valve repair. However, severe acute AI does not respond well to medication, and re-operation means higher risk to the patients; the most effective therapeutic strategies for LVAD-induced AI still need further exploration. In this report, we present the first described case of new-onset, severe LVAD-induced AI in China with a patient who underwent transcatheter aortic valve replacement (TAVR) and achieved significant improvement in functional capacity and symptoms with lower operation risk.

Authors

  • Xiaodong Wang
    Cardiovascular Department, TEDA International Cardiovascular Hospital, Tianjin, China.
  • Yujie Lu
    Cardiovascular Department, TEDA International Cardiovascular Hospital, Tianjin, China.
  • Zhigang Liu
    Cardiac Surgery, TEDA International Cardiovascular Hospital, Tianjin, China.
  • Antonino S Rubino
    Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", AORN dei Colli, Cardiac Surgery, Vincenzo Monaldi Hospital, Naples, Italy.
  • Bartlomiej Perek
    Department of Cardiac Surgery and Transplantology, Poznan University of Medical Sciences, Poznan, Poland.
  • Daniel Wendt
    Department of Thoracic and Cardiovascular Surgery, Westgerman Heart and Vascular Center, Essen, Germany.
  • Calogera Pisano
    Cardiac Surgery Unit, Department of Surgical Science, Tor Vergata University Hospital, Rome, Italy.
  • Guillaume Goudot
    Vascular Medicine Department, Hôpital Européen Georges Pompidou, AP-HP, Université Paris Cité, INSERM U970 PARCC, Paris, France.
  • Oliver Deutsch
    Department of Cardiovascular Surgery, German Heart Centre Munich, Munich, Germany.
  • Xiaocheng Liu
    Cardiac Surgery, TEDA International Cardiovascular Hospital, Tianjin, China.

Keywords

No keywords available for this article.